circRNA basic information
circBase ID: hsa_circ_0006282
Name: -
Synonym: -
Host Gene: -
Genomic location(hg19): chr8:74868145-74872053:-
Genomic location(hg38): chr8:73955910-73959818:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0001056
MONDO name: gastric cancer
Disease details: gastric cancer
Disease DO ID:
10534
Disease MeSH ID:
-
Disease NCIt ID:
C9331
Disease ICD11 ID:
1397617262
Disease OMIM ID:
613659
Species: Human
Species details: Homo sapiens
Tissue specimen:

GC tissues; adjacent non-tumor tissues

Cell lines:

BGC-823; MKN-45; AGS; HGC-27; GES-1

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: FBXO22
Associated microRNA: miR-155
Biological function: promotes proliferation, migration, invasion and tumor growth of gastric cancer cells
Molecular mechanism: Acts as a ceRNA sponging miR-155 to upregulate FBXO22 expression
Biological pathway or process:

ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; RNase R Treatment; Back-Splice Junction PCR / divergent primers PCR; CCK8; Colony Formation Assay; Transwell Assay; Luciferase Reporter Assay; Western Blot; Nuclear-Cytoplasmic Fractionation; Transfection; Clinical Sample Validation; In Vivo Animal Model; IHC (Immunohistochemistry)

Clinical significance:

Over-expression of circ_0006282 was associated with tumor size, lymph nodes metastasis and TNM stage

Description:

circ_0006282 is up-regulated in gastric cancer tissues and cell lines and promotes malignant behaviors (proliferation, migration/invasion, and xenograft growth). Mechanistically, it mainly localizes in the cytoplasm and functions as a ceRNA that sponges miR-155, thereby upregulating FBXO22 to drive GC progression.

Confidence score:

0.8034

Other information
Title:

Circular RNA circ_0006282 Contributes to the Progression of Gastric Cancer by Sponging miR-155 to Upregulate the Expression of FBXO22.

Journal: OncoTargets and therapy
Published: 2020
PubMed ID: 32099403
Study type:

combined biological and clinical study

Data availability: -
Code availability: -